Through a Board of Directors (CA) and a Scientific Committee (CS), both comprising clinician and biologist investigators, ALFA has the following objectives:
- To initiate and promote any research in adult AML biology and treatment
- To collect and manage the funds for this purpose
- To support ALFA members in the acquisition of new competences and knowledge in the AML field
- To diffuse knowledge and promote training in this field
- To encourage and facilitate connections between the actors of AML patients’ care and research on AML, including universities, hospitals, private companies, charity structures and patients’ associations
- To contribute to a better equipment and management of hospital clinical units and laboratories, as well as university research labs.
- To support contacts with other national, European, and international cooperative groups or societies working in the AML field.
The means of action are:
- The organization of periodic scientific or teaching meetings
- The realization of clinical and biological research studies
- The design, promotion, and coordination of its own clinical, biological, and therapeutically studies and trials
- The participation in studies and trials from other cooperative groups
- The analysis and publication of the results of these studies and trials (original articles, reviews, thesis…)
- The participation in national and international conferences, workshops, and scientific meetings
- The employment of assistant persons for study/trial monitoring or meeting organization.
